http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106701679-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2318 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2312 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M23-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M23-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
| filingDate | 2016-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106701679-B |
| titleOfInvention | NK cell expansion ex vivos culture medium combines and cultural method |
| abstract | This disclosure relates to a kind of NK cell expansion ex vivos culture medium combination and cultural method, the culture medium combination, including basal medium, inducing culture, proliferated culture medium and activation acclimatizing culture medium；The constituent of the basal medium includes：The culture mediums of RPMI 1640, GT T551 culture mediums, gentamicin and BSA；The constituent of the inducing culture includes：The culture mediums of RPMI 1640, GT T551 culture mediums, BSA, lentinan, GL-B, Tea Polyphenols, allicin and taxol；The constituent of the proliferated culture medium includes：The culture mediums of RPMI 1640, GT T551 culture mediums, BSA, interleukins；The activation acclimatizing culture medium includes：The culture mediums of RPMI 1640, GT T551 culture mediums, insulin, transferrins and glutamine.Pass through above-mentioned technical proposal, the NK cell quantities that the combination of NK cell expansion ex vivos culture medium and method culture provided using the disclosure is obtained are more, also have higher activity in clinical treatment. |
| priorityDate | 2016-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.